Page last updated: 2024-10-30

mecamylamine and Brain Concussion

mecamylamine has been researched along with Brain Concussion in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Brain Concussion: A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lyeth, BG1
Dixon, CE1
Hamm, RJ1
Jenkins, LW1
Young, HF1
Stonnington, HH1
Hayes, RL1

Other Studies

1 other study available for mecamylamine and Brain Concussion

ArticleYear
Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat.
    Brain research, 1988, May-10, Volume: 448, Issue:1

    Topics: Animals; Blood Pressure; Brain; Brain Concussion; Heart Rate; Male; Mecamylamine; N-Methylscopolamin

1988